Malignant tumors are one of the main diseases leading to death, and the vigorous
development of nanotechnology has opened up new frontiers for antitumor therapy …

Ruthenium (II)-based coordination complexes have emerged as photosensitizers (PSs) for
photodynamic therapy (PDT) in oncology as well as antimicrobial indications and have great …

Metronomic (that is, low-dose and long-term) photodynamic therapy (mPDT) for treating
internal lesions requires the stable fixation of optical devices to internal tissue surfaces to …

Long-term and low-dose photodynamic therapy for treating tumors requires a sustainable
energy supply. The power source technology of batteries and wireless charging for driving a …

Simple Summary Malignant gliomas are of the deadliest, most hard-to-treat cancers, given
their various characteristics of aggression and infiltration as well as the location of growth …

The poor outcome of primary malignant brain tumours is predominantly due to local invasion
and local recurrence and their prognosis is highly dependent on the degree of resection …

Metronomic photodynamic therapy (mPDT) is a form of PDT that induces cancer cell death
by intermittent continuous irradiation with a relatively weak power of light for a long duration …

Metronomic photodynamic therapy (mPDT), which induces cancer cell death by prolonged
intermittent continuous irradiation at lower light power, has profoundly promising …

Photodynamic therapy (PDT) has recently gained attention as an alternative treatment of
malignant gliomas. Glioblastoma (GBM) is the most prevalent within tumors of the central …

Malignant glioma remains one of the most aggressive intracranial tumors with devastating
clinical outcomes despite the great advances in conventional treatment approaches …